If I need to shout it from the rooftops, that's what I will do
At 27, Tim began experiencing symptoms that doctors attributed to youth rather than illness — a quiet but consequential error that allowed stage four bowel cancer to take root and spread before anyone looked closely enough. His story, unfolding over three years of surgeries and chemotherapy in Cornwall and London, speaks to a structural blind spot in medicine: the assumption that age alone can rule out serious disease. Now, as his family fundraises to afford an experimental treatment the NHS cannot administer, Tim's journey raises enduring questions about who the healthcare system is designed to see, and who it overlooks.
- Months of dismissed symptoms and an IBS misdiagnosis meant Tim's cancer had already reached his lungs by the time emergency surgery confirmed the truth.
- His sister Ann identifies the core failure as systemic — bowel cancer screening targets the over-50s, leaving younger patients invisible to the very instincts doctors are trained to follow.
- COVID restrictions stripped the family of the ability to be physically present through surgeries and treatments, compounding medical trauma with enforced isolation.
- A compassionate trial drug offers real hope, but a funding gap between NHS provision and administration costs leaves the family paying up to £2,000 a month they do not have.
- A GoFundMe campaign has raised £1,775 of a £10,000 target, with a mother working extra shifts and a sister vowing to 'shout from the rooftops' to keep her brother alive.
Tim was 27 when persistent pain in his side was dismissed by doctors who told him he was simply too young for bowel cancer. The diagnosis offered instead was IBS. In August 2019, he collapsed at work and was rushed to A&E, where the real picture emerged: stage four bowel cancer, already spread to his lungs. Emergency surgery removed two tumours and left him with a stoma. The months of delay had already narrowed his options.
Now 30, Tim has spent three years cycling through chemotherapy and multiple operations. His sister Ann, who lives far from him, frames the original failure as structural rather than personal — doctors are trained to look for bowel cancer in people over 50, and that training shapes what they see and what they miss. The pandemic deepened the family's isolation, with Ann unable to travel to support her brother through treatment, and her daughter having met her uncle only twice.
A recent development brought both hope and a new obstacle. Tim was offered a place in an experimental drug trial on compassionate grounds, at no cost for the medication itself — but the NHS cannot administer it, leaving the family responsible for costs estimated between £1,000 and £2,000 per month. Ann launched a GoFundMe campaign targeting £10,000. Their mother has taken on extra shifts. The family, she says, is running out of options. 'If I need to shout it from the rooftops and beg for help to keep my brother here,' she said, 'then that's what I will do.'
Tim was 27 when his body began sending signals that something was wrong. For months he felt a sharp, persistent pain in his side, but when he described it to doctors, they told him he was too young for bowel cancer. The diagnosis they offered instead was irritable bowel syndrome—a condition that would pass, they assured him. It didn't. In August 2019, he became acutely ill at work and was rushed to A&E. Within days, the truth emerged: he had stage four bowel cancer, and it had already spread to his lungs.
Tim, who grew up in St Stephen near St Austell but had moved to London, underwent emergency surgery to remove two tumours from his bowel and have a stoma placed. He was 27 years old. The months of delay—months when a diagnosis might have caught the cancer earlier and made treatment more manageable—had already cost him. Now 30, he has endured multiple rounds of chemotherapy and several operations across three years, and his treatment continues.
His sister Ann carries the weight of what might have been. She doesn't want to assign blame, she says, but the feeling of being let down is real. "The earlier you receive a diagnosis of bowel cancer, the easier it is to treat it," she explained. The problem, as she sees it, is structural: doctors are trained to look for bowel cancer in people in their 50s. If they're not told to look for it in someone younger, they won't. The assumption of age becomes a barrier to seeing what's actually there.
The pandemic compounded the family's struggle. Ann lives far from her brother, and Covid restrictions meant she couldn't be there to support him through surgeries and treatments while he worked remotely to keep himself afloat. She describes the helplessness of watching from a distance, unable to help. Her daughter has met her uncle only twice. "With every passing Christmas and birthday, you can't help but think he might not make it to the next one," Ann said. The five-year life expectancy for stage four bowel cancer hangs over every family gathering.
Then came what Ann calls a lifeline: Tim was offered a place in a trial for an experimental drug, offered to him on compassionate grounds at no cost. But there was a catch. The NHS cannot administer the trial medication, which means the family must pay for its administration themselves. The treatment is estimated to cost between £1,000 and £2,000 per month, and the family doesn't yet know how many months of treatment Tim will need.
Ann set up a GoFundMe campaign with a target of £10,000. As of the time she spoke to the press, she had raised £1,775. The family comes from a single-parent household. Everyone works hard. Their mother has taken on extra shifts to contribute. But they cannot afford the full cost on their own. "We're getting desperate and we are running out of options," Ann said. "If I need to shout it from the rooftops and beg for help to keep my brother here, then that's what I will do."
Tim's story sits at the intersection of two healthcare failures: the initial delay caused by age-based assumptions about who gets sick, and the current gap in how experimental treatments are funded and delivered. It raises uncomfortable questions about access to potentially life-saving care, and about who bears the burden when the system cannot or will not.
Citas Notables
The earlier you receive a diagnosis of bowel cancer, the easier it is to treat it. Doctors tend to look out for it in people who are in their 50s, so if they're not told to look for it in someone younger, then they won't.— Ann, Tim's sister
We're getting desperate and we are running out of options. If I need to shout it from the rooftops and beg for help to keep my brother here, then that's what I will do.— Ann
La Conversación del Hearth Otra perspectiva de la historia
Why do you think doctors dismissed Tim's symptoms so quickly?
Because bowel cancer in people under 50 is rare enough that it doesn't live in the front of a doctor's mind. When you're trained to look for something in a certain demographic, you can miss it entirely in someone who doesn't fit the profile.
But he had months of pain. Didn't that raise any flags?
It should have. But IBS is common, it's vague, and it affects young people. Once that diagnosis is offered, it becomes the frame through which everything else is interpreted. The pain fits the story they've already told.
And now he's in a trial for a new drug. That sounds hopeful.
It is hopeful, but it's also a kind of cruelty. He's been offered access to something that might save his life, but only if his family can pay thousands of pounds a month to have it administered. The drug itself is free. The delivery of it isn't.
What does that say about how we treat experimental treatments?
It says that access to hope is still rationed by money. And it says that families like Tim's have to choose between financial ruin and their loved one's survival.
Do you think his story will change how doctors approach younger patients?
It should. But change is slow. What matters now is that people understand: cancer doesn't check your age before it arrives.